Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis

BACKGROUND: Recent trials have provided robust evidence demonstrating that endocrine therapy with/without targeted therapy, such as cyclin-dependent kinase 4/6 inhibitors or mTOR (mammalian target of rapamycin) inhibitors, effectively halts disease progression in hormone receptor (HR)-positive and h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Breast Care (Basel)
Main Authors: Cha, Chihwan, Ahn, Sung Gwe, Yoo, Tae-Kyung, Kim, Kun Min, Bae, Soong June, Yoon, Changik, Park, Soeun, Sohn, Joohyuk, Jeong, Joon
Format: Artigo
Sprog:Inglês
Udgivet: S. Karger GmbH 2020
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490659/
https://ncbi.nlm.nih.gov/pubmed/32982652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503847
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker